EBD Group is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.



Cell & Gene Therapies State of the Industry Briefing

Monday, January 7, 8:00-10:45 am 
Parc 55 San Francisco, Cyril Magnin Ballroom

The Alliance for Regenerative Medicine will host its 9th Annual Cell & Gene Therapies State of the Industry Briefing, a top-level gathering for key stakeholders in the field. This event – which is free and open to the public – will highlight the commercialization of cell-based therapies for oncology, as well as an in-depth conversation between top CEOs and executives regarding future inflection points for gene therapies expected in 2019. With an anticipated audience of over 500, this session is the largest cell and gene therapy-focused event taking place during JP Morgan week.

The Future of AI-powered healthcare at Digital Medicine & Medtech Showcase

Monday, January 7, 4:00-5:00 pm 
Parc 55 San Francisco, Cyril Magnin Ballroom

Discover the AI and Machine learning applications that will have the most profound impact on the healthcare system. This panel, representing AAIH member companies, will highlight what is possible, what is standing in the way, and what is science fiction. Panelists will also provide information on what investors and partners should consider before engaging in financing or co-development with AI healthcare companies. 

The Shifting Model – How new era, patient-led collaborations are transforming drug discovery and development in rare disease, and beyond. Presented by Global Genes.

Tuesday, January 8, 4:30-5:15 pm
Hilton San Francisco Union Square, Imperial Ballroom

Previously, patient involvement began with advocating for research, followed by focusing on access to drugs and development. Today, the shortcomings of traditional drug development have led to the emergence of new technologies allowing rare disease communities to aggregate data and establish collaborative partnerships with industry. Learn who and what’s behind these collaborations and the implications that stretch even beyond rare disease in an engaging stand-and-deliver format.

Australia's 41% R&D refund and simplified regulatory environment as a gateway to Asia.

Tuesday, January 8, 5:30 pm
Parc 55 San Francisco, Cyril Magnin Ballroom I

  • Australia’s scientific talent, excellent medical infrastructure and lucrative R&D cash refund scheme makes it a preferred destination for early phase clinical trials.
  • Biotech Connect, a single access point to the Australian R&D ecosystem. From clinical trial management, Phase 1 unit service and set up of Australian legal entity
  • Patient availability makes Asia a key region to accelerate later phase development, at lower costs.
  • The partnership between regional specialists, an alternative to large global CRO to manage complex global trial.
The Readout Live: A conversation with STAT's biotech team

Wednesday, January 9, 4:30-5:15 pm
Hilton San Francisco Union Square, Imperial Ballroom

After days of trekking in and around Union Square, join STAT's biotech team for a no-holds-barred conversation about the week that was and the year to come. Reporters Adam Feuerstein, Damian Garde, and Rebecca Robbins will break down the most important news stories that you should take away from the week. Then they'll talk about the biggest biotech stories and newsmakers to watch in 2019. Come ready to ask them questions.

Additional Events

China Showcase

Sunday, January 6, 10:00 am - 5:30 pm
Parc 55 San Francisco, Level 4, Cyril Magnin Ballroom

Meet and network with top bio pharmaceutical companies and investors seeking global opportunities during Biotech Showcase.

Digital Medicine & Medtech Showcase

Monday -  Wednesday, January 7-9
Parc 55 San Francisco, Level 4, Market Street

At the intersection of technology and medicine: Digital Medicine & Medtech Showcase